Product Code: GVR-3-68038-060-6
Veterinary Pain Management Market Growth & Trends:
The global veterinary pain management market size is expected to reach USD 3.82 billion in 2030 and is projected to grow at a CAGR of 6.80% from 2025 to 2030. The primary drivers of market growth include the advent of monoclonal antibodies in OA associated pain control, rising prevalence of diseases in animals such as osteoarthritis, rising pet ownership, increasing number of veterinarians, and increasing animal health expenditure. In May 2023, Zoetis's Librela mAb received the U.S. FDA approval for use in dog OA pain control. Moreover, pet insurance adoption is increasing due to a number of factors, including pet humanization, a growing pet population, greater initiatives by major companies, and rising veterinary care expenses.
Increasing number of veterinarians is expected to fuel the market growth. For instance, according to AVMA, there were a total of 127,131 vet practitioners in the U.S. veterinarians are now better equipped with tools and knowledge to identify and address pain in animals, whether it's acute or chronic. Moreover, there's a greater emphasis on educating veterinarians about recognizing and managing pain in animals. Veterinary schools are incorporating pain management into their curricula, and continuing education programs keep practicing veterinarians up-to-date on the latest techniques and medications. Overall, the increasing number of veterinarians driving the veterinary pain management market reflects a positive shift towards better care and understanding of animals' needs, aligning with the broader trend of humanizing pets and recognizing their emotional and physical well-being.
Veterinary pain management has become a crucial aspect of pet care, particularly with conditions such as cancer, where pain can be a significant symptom. With the increase in cancer cases among dogs, there's likely a corresponding increase in the demand for effective pain management solutions in veterinary practice. Approximately fifty percent of dogs over the age of ten develop cancer. Cancer in dogs occurs at a rate similar to that of humans. There are certain cancers that affect cats more frequently than dogs, like lymphoma. In order to help manage pain in dogs with cancer, veterinarians frequently combine pharmaceuticals, such as analgesics and anti-inflammatory medicines, with complementary therapies, such as acupuncture and physical therapy.
Furthermore, key mergers and acquisitions, regional expansions, product launches, etc., to increase their foothold in the market. For instance, in January 2024, Ceva acquired Scout Bio, a leading biotechnology firm specializing in advanced therapies for pets. This acquisition marks a substantial advancement for Ceva, granting access to groundbreaking treatments such as monoclonal antibodies and gene therapy aimed to tackle chronic pet diseases.
Veterinary Pain Management Market Report Highlights:
- The NSAIDs segment led the market with the largest revenue share of 85% in 2024. and is anticipated to grow at a lucrative CAGR over the forecast period
- Based on indication, the osteoarthritis (OA) segment led the market with the largest revenue share of 68.11%in 2024
- Based on animal, the production animals segment led the market with the largest with the largest revenue share of 64% in 2024.
- Based on route of administration, the oral segment led the market with the largest revenue share of 43.55% in 2024
- Based on mode of purchase, the prescription segment led the market with the largest revenue share of 84.05% in 2024
- Based on end use, the hospitals & clinics segment led the market with the largest revenue share of 82.49% in 2024
- North America dominated the veterinary pain management market with the largest revenue share of 39.56% in 2024
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Market Definitions
- 1.7. Model Details
- 1.8. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary Pain Management Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Evolving Treatment Methodologies
- 3.2.1.2. Rising Awareness Initiatives
- 3.2.1.3. Increasing R&D Initiatives
- 3.2.1.4. Rising Prevalence Of Associated Health Conditions
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Possible Adverse Effects Of Pain Management Medications
- 3.2.2.2. Intense Regulatory Scrutiny
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Veterinary Pain Management Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Estimated Companion Animal Population, by key species & key countries, 2018-2024
- 3.3.4. COVID-19 Impact Analysis
Chapter 4. Veterinary Pain Management Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Veterinary Pain Management Market: Product Movement Analysis & Market Share, 2024 & 2030
- 4.3. NSAIDs
- 4.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Anesthetics
- 4.4.1. Anesthetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Opioids
- 4.5.1. Opioids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Pain Management Market: Indication Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Veterinary Pain Management Market: Indication Movement Analysis & Market Share, 2024 & 2030
- 5.3. Osteoarthritis (OA)
- 5.3.1. Osteoarthritis (OA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Postoperative Pain
- 5.4.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Pain Management Market: Animal Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Veterinary Pain Management Market: Animal Movement Analysis & Market Share, 2024 & 2030
- 6.3. Production Animals
- 6.3.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Companion Animals
- 6.4.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Pain Management Market: Route of Administration Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Veterinary Pain Management Market: Route of Administration Movement Analysis & Market Share, 2024 & 2030
- 7.3. Parenteral
- 7.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Oral
- 7.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Topical
- 7.5.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary Pain Management Market: Mode of Purchase Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Veterinary Pain Management Market: Mode of Purchase Movement Analysis & Market Share, 2024 & 2030
- 8.3. Prescription
- 8.3.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. OTC
- 8.4.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Veterinary Pain Management Market: End Use Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Veterinary Pain Management Market: End Use Movement Analysis & Market Share, 2024 & 2030
- 9.3. Hospitals & Clinics
- 9.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4. Others
- 9.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Veterinary Pain Management Market: Regional Estimates & Trend Analysis
- 10.1. Regional Outlook
- 10.2. Veterinary Pain Management Market: Regional Movement Analysis & Market Share, 2024 & 2030
- 10.3. Regional Marketplace: Key Takeaways
- 10.4. North America
- 10.4.1. North America Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.4.2. U.S.
- 10.4.2.1. Key Country Dynamics
- 10.4.2.2. U.S. Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.4.3. Canada
- 10.4.3.1. Key Country Dynamics
- 10.4.3.2. Canada Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.4.4. Mexico
- 10.4.4.1. Key Country Dynamics
- 10.4.4.2. Mexico Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5. Europe
- 10.5.1. Europe Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.2. UK
- 10.5.2.1. Key Country Dynamics
- 10.5.2.2. UK Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.3. Germany
- 10.5.3.1. Key Country Dynamics
- 10.5.3.2. Germany Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.4. France
- 10.5.4.1. Key Country Dynamics
- 10.5.4.2. France Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.5. Italy
- 10.5.5.1. Key Country Dynamics
- 10.5.5.2. Italy Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.6. Spain
- 10.5.6.1. Key Country Dynamics
- 10.5.6.2. Spain Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.7. Denmark
- 10.5.7.1. Key Country Dynamics
- 10.5.7.2. Denmark Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.8. Norway
- 10.5.8.1. Key Country Dynamics
- 10.5.8.2. Norway Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.5.9. Sweden
- 10.5.9.1. Key Country Dynamics
- 10.5.9.2. Sweden Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6. Asia Pacific
- 10.6.1. Asia Pacific Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.2. Japan
- 10.6.2.1. Key Country Dynamics
- 10.6.2.2. Japan Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.3. China
- 10.6.3.1. Key Country Dynamics
- 10.6.3.2. China Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.4. India
- 10.6.4.1. Key Country Dynamics
- 10.6.4.2. India Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.5. South Korea
- 10.6.5.1. Key Country Dynamics
- 10.6.5.2. South Korea Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.6. Australia
- 10.6.6.1. Key Country Dynamics
- 10.6.6.2. Australia Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.6.7. Thailand
- 10.6.7.1. Key Country Dynamics
- 10.6.7.2. Thailand Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.7. Latin America
- 10.7.1. Latin America Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.7.2. Brazil
- 10.7.2.1. Key Country Dynamics
- 10.7.2.2. Brazil Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.7.3. Argentina
- 10.7.3.1. Key Country Dynamics
- 10.7.3.2. Argentina Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.8. Middle East & Africa
- 10.8.1. Middle East & Africa Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.8.2. South Africa
- 10.8.2.1. Key Country Dynamics
- 10.8.2.2. South Africa Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.8.3. Saudi Arabia
- 10.8.3.1. Key Country Dynamics
- 10.8.3.2. Saudi Arabia Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.8.4. UAE
- 10.8.4.1. Key Country Dynamics
- 10.8.4.2. UAE Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.8.5. Kuwait
- 10.8.5.1. Key Country Dynamics
- 10.8.5.2. Kuwait Veterinary Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
- 11.1. Market Participant Categorization
- 11.2. Key Company Profiles
- 11.2.1. Boehringer Ingelheim
- 11.2.1.1. Company Overview
- 11.2.1.2. Financial Performance
- 11.2.1.3. Solutions Benchmarking
- 11.2.1.4. Strategic Initiatives
- 11.2.2. Vetoquinol
- 11.2.2.1. Company Overview
- 11.2.2.2. Financial Performance
- 11.2.2.3. Solutions Benchmarking
- 11.2.2.4. Strategic Initiatives
- 11.2.3. Ceva Animal Health Llc
- 11.2.3.1. Company Overview
- 11.2.3.2. Financial Performance
- 11.2.3.3. Solutions Benchmarking
- 11.2.3.4. Strategic Initiatives
- 11.2.4. Chanelle Pharma (Exponent)
- 11.2.4.1. Company Overview
- 11.2.4.2. Financial Performance
- 11.2.4.3. Solutions Benchmarking
- 11.2.4.4. Strategic Initiatives
- 11.2.5. Elanco
- 11.2.5.1. Company Overview
- 11.2.5.2. Financial Performance
- 11.2.5.3. Solutions Benchmarking
- 11.2.5.4. Strategic Initiatives
- 11.2.6. Dechra Pharmaceuticals Llc (EQT Group)
- 11.2.6.1. Company Overview
- 11.2.6.2. Financial Performance
- 11.2.6.3. Solutions Benchmarking
- 11.2.6.4. Strategic Initiatives
- 11.2.7. Zoetis
- 11.2.7.1. Company Overview
- 11.2.7.2. Financial Performance
- 11.2.7.3. Solutions Benchmarking
- 11.2.7.4. Strategic Initiatives
- 11.2.8. Merck & Co, Inc.
- 11.2.8.1. Company Overview
- 11.2.8.2. Financial Performance
- 11.2.8.3. Solutions Benchmarking
- 11.2.8.4. Strategic Initiatives
- 11.2.9. Norbrook
- 11.2.9.1. Company Overview
- 11.2.9.2. Financial Performance
- 11.2.9.3. Solutions Benchmarking
- 11.2.9.4. Strategic Initiatives
- 11.2.10. Assisi (Wind Point Partners)
- 11.2.10.1. Company Overview
- 11.2.10.2. Financial Performance
- 11.2.10.3. Solutions Benchmarking
- 11.2.10.4. Strategic Initiatives
- 11.2.10.5. Strategic Initiatives
- 11.3. Heat Map Analysis/ Company Market Position Analysis
- 11.4. List of Key Market Players